ArticleCancer immunology, immunotherapy : CII2022

Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapy.

Phei San Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.